9013-56-3

Basic information

• Product Name: COAGULATION FACTOR XIII, HUMAN
• Synonyms: FIBRIN-STABILIZING FACTOR;FIBRIN-STABILIZING FACTOR, HUMAN;FACTOR XIII (HUMAN);HUMAN PLASMA FACTOR XIII;COAGULATION FACTOR XIII, HUMAN;COAGULATION FACTOR XIII, HUMAN PLASMA
• CAS NO: 9013-56-3
• Molecular Weight: 0
• Mol File: 9013-56-3.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: -20C
• CAS DataBase Reference: COAGULATION FACTOR XIII, HUMAN(CAS DataBase Reference)
• NIST Chemistry Reference: COAGULATION FACTOR XIII, HUMAN(9013-56-3)
• EPA Substance Registry System: COAGULATION FACTOR XIII, HUMAN(9013-56-3)

Safety Data

• Hazardous Substances Data: 9013-56-3(Hazardous Substances Data)

Usage

Description

COAGULATION FACTOR XIII, HUMAN is a tetramer enzyme (α2β2) derived from human plasma, composed of two identical α-subunits and two identical β-subunits. It plays a crucial role in the final stages of blood coagulation by strengthening the fibrin clot through the formation of glutamyl-lysine bonds between fibrin monomers after thrombin cleavage and calcium ion (Ca2+) activation.
Used in Medical Industry:
COAGULATION FACTOR XIII, HUMAN is used as a therapeutic agent for promoting wound healing and tissue repair. It is applied to enhance the stability and strength of the fibrin clot, which is essential for the healing process in various medical procedures, including surgery, trauma, and burns.
Used in Research Applications:
COAGULATION FACTOR XIII, HUMAN is used as a research tool for studying the molecular mechanisms of blood coagulation, fibrin clot formation, and the role of Factor XIII in various physiological and pathological processes. It aids in understanding the structure, function, and regulation of this enzyme, which can contribute to the development of novel therapeutic strategies for coagulation disorders and related conditions.